Skip to Content


HOUSE DOCKET, NO. 2075         FILED ON: 1/20/2011

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 2051

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Robert F. Fennell

_______________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
              Court assembled:

              The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to diagnostic screening for prostate cancer. .

_______________

PETITION OF:

 

Name:

District/Address:

Robert F. Fennell

10th Essex

Christine E. Canavan

10th Plymouth

Martha M. Walz

8th Suffolk

James J. O'Day

14th Worcester

Louis L. Kafka

8th Norfolk

Kevin G. Honan

17th Suffolk

Brian M. Ashe

2nd Hampden

Frank I. Smizik

15th Norfolk

Sal N. DiDomenico

Middlesex, Suffolk, and Essex

Cory Atkins

14th Middlesex

Carlo Basile

1st Suffolk

Walter F. Timilty

7th Norfolk


HOUSE DOCKET, NO. 2075        FILED ON: 1/20/2011

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 2051

By Mr. Fennell of Lynn, a petition (accompanied by bill, House, No. 2051) of Robert F. Fennell and others that health insurance providers be required to include coverage for diagnostic screening for prostate cancer.  Financial Services. 

 

[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 898 OF 2009-2010.]


The Commonwealth of Massachusetts
 

_______________

In the Year Two Thousand Eleven

_______________

 

An Act relative to diagnostic screening for prostate cancer. .
 

              Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

              SECTION 1.  Notwithstanding any general or special law to the contrary,  every contract which provides coverage for hospital, surgical or medical care shall provide the following coverage for diagnostic screening for prostatic cancer:(i) upon the recommendation of a physician, medically recognized diagnostic testing including, but not limited to, a digital rectal examination, transrectal ultrasonography and prostate-specific antigen test at any age for covered persons having a prior history of prostate cancer; and (ii) an annual medically recognized diagnostic examination including, but not limited to, a digital rectal examination, trans-rectal ultrasonography and a prostate-specific antigen test for all men aged forty and over.

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

Error